Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US
연구 개요
This study will test olatorepatide (study drug) to determine how safe and effective this drug is and how easily your body can accept this drug without causing side effects, as well as how the drug is processed in the body by participants with overweight or obesity. The study will test how safe and effective the study drug works compared to placebo in people who are overweight or obese but do not have diabetes. The study is looking at: * What side effects the study drug might cause * How much the study drug is in the blood at different times * How well the study drug works * If the body makes antibodies to the study drug as this may cause the study drug to not work as well
- 스폰서
- 리드: 리제네론
- 적응증
- Overweight or Obesity
- 중재
- Olatorepatide, Placebo
- 목표 등록
- 120명
- 시작일
- 2026-03-16
- 완료(예정)
- 2026-12-18
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.